Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Ppublish 50 citations
PubMed: 30020457 DOI: 10.1210/jc.2018-00433
Youth With Type 1 Diabetes Have Adipose, Hepatic, and Peripheral Insulin Resistance.
J Clin Endocrinol Metab 103(10):3647-3657
Authors: Melanie Cree-Green, Jacob J Stuppy, Jessica Thurston, Bryan C Bergman, Gregory V Coe, Amy D Baumgartner, Samantha Bacon, Ann Scherzinger, Laura Pyle, Kristen J Nadeau
Affiliations
- Department of Pediatrics, Division of Pediatric Endocrinology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
- Barbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
- Department of Biomedical Sciences and Biotechnology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
- Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, Colorado.
- Department of Medicine, Division of Endocrinology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
- Department of Radiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
- Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Abstract
Context
Adolescents with type 1 diabetes (T1D) have difficulty obtaining optimal glucose control, which may relate to insulin resistance (IR), especially during puberty. Moreover, IR increases the risk for cardiovascular disease, the leading cause of death in T1D. However, the tissue specificity of IR in adolescents with T1D has not been fully phenotyped.
Objective
To assess adipose, hepatic, and peripheral insulin sensitivity in adolescents with and without T1D.
Design and Setting
Thirty-five youth with T1D [median age, 16 (first and third quartiles, 14, 17) years; 53% female; median body mass index (BMI) percentile, 82nd (55th, 96th); late puberty; median hemoglobin A1c, 8.3% (7.3%, 9.4%)] and 22 nondiabetic youth of similar age, BMI, pubertal stage, and level of habitual physical activity were enrolled. Insulin action was measured with a four-phase hyperinsulinemic euglycemic clamp (basal and 10, 16, and 80 mU/m2/min) with glucose and glycerol isotope tracers.
Results
Adolescents with T1D had a significantly higher rate of lipolysis (P < 0.0001) and endogenous glucose production (P < 0.001) and lower peripheral glucose uptake (glucose rate of disappearance, 6.9 ± 2.9 mg/kg/min for patients with T1D vs 11.3 ± 3.3 for controls; P < 0.0001) during hyperinsulinemia compared with controls. In youth with T1D, glucose rate of disappearance correlated with free fatty acid at the 80-mU/m2/min phase (P = 0.005), markers of inflammation (IL-6; P = 0.012), high-sensitivity C-reactive protein (P = 0.001), and leptin (P = 0.008)], but not hemoglobin A1c.
Conclusions
Adolescents with T1D have adipose, hepatic and peripheral IR. This IR occurs regardless of obesity and metabolic syndrome features. Youth with T1D may benefit from interventions directed at improving IR in these tissues, and this area requires further research.
MeSH
Diabetes Mellitus, Endocrinology, Hemoglobins, Insulin Resistance, Insulin, Puberty, C-Reactive Protein, Adolescent, Tissues, Diabetes Mellitus, Type 1
Cited by
- What can we learn from β-cell failure biomarker application in diabetes in childhood? A systematic review. World J Diabetes, 2021
- Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance. Endocr Rev, 2025
- Nutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications. Front Endocrinol (Lausanne), 2021
- Relative Hypoxia and Early Diabetic Kidney Disease in Type 1 Diabetes. Diabetes, 2021
- Bromocriptine quick-release as adjunct therapy in youth and adults with type 1 diabetes: A randomized, placebo-controlled crossover study. Diabetes Obes Metab, 2022
- Concentric remodeling and the metabolic-associated steatotic liver disease in patients with type 1 diabetes: an exploratory study. Acta Diabetol, 2025
- Youth-Onset Type 2 Diabetes: What We've Learned From Key Youth-Onset Type 2 Diabetes Studies, What We Still Don't Know, and Why It Is Important. Diabetes Care, 2025
- Higher NADH Dehydrogenase [Ubiquinone] Iron-Sulfur Protein 8 (NDUFS8) Serum Levels Correlate with Better Insulin Sensitivity in Type 1 Diabetes. Curr Issues Mol Biol, 2022
- Protective effects of physical activity against health risks associated with type 1 diabetes: "Health benefits outweigh the risks". World J Diabetes, 2022
- The Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 Diabetes. Diabetes, 2020
- Muscle Insulin Resistance in Youth with Obesity and Normoglycemia is Associated with Altered Fat Metabolism. Obesity (Silver Spring), 2020
- Vascular and Myocardial Structure and Function in Adolescents with Type 1 Diabetes: The CARDEA Study. Pediatr Diabetes, 2025
- The Effects of Resistance Exercise Training on Skeletal Muscle Metabolism and Insulin Resistance Development in Female Rodents with Type 1 Diabetes. J Diabetes Res, 2024
- Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes. J Clin Endocrinol Metab, 2020
- Systematic assessment of streptozotocin-induced diabetic metabolic alterations in rats using metabolomics. Front Endocrinol (Lausanne), 2023
- Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review. Curr Diab Rep, 2019
- Complete blood counts with red blood cell determinants associate with reduced beta-cell function in seroconverted Swedish TEDDY children. Endocrinol Diabetes Metab, 2022
- Acanthosis Nigricans in Children and Adolescents with Type 1 Diabetes or Obesity: The Potential Interplay Role between Insulin Resistance and Excess Weight. Children (Basel), 2021
- Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance. Am J Physiol Endocrinol Metab, 2019
- Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2). Diabetes, 2020